Aim: The association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and intervillous and decidual pathology in patients with pregnancy loss was investigated. Methods: We performed a cross-sectional study on 243 patients presenting with pregnancy loss for the degree of intervillous fibrin and thrombosis (IT), and decidual fibrin and thrombosis (DT) and determined their MTHFR C677T genotypes. Overall differences in age, body mass index (BMI), gravidity, parity, number of pregnancy losses and gestational period when the pathologic samples were obtained, also were determined. Results: There were no significant differences in age, BMI, gravidity, parity, number of pregnancy losses and gestational period, relative to MTHFR C677T genotype (TT vs CT vs CC). There were significantly more T allele carriers and TT genotype patients among patients with severe IT (odds ratio [OR] 1.653, P = 0.033 and OR 2.246, P = 0.032, respectively) and those with severe IT and decidual thrombosis (OR 2.602, P = 0.012 and OR 3.375, P = 0.035, respectively). The CC genotype was protective against the four studied pathologic grades. Conclusion: To our knowledge, this is the first study showing that the MTHFR C677T TT genotype and T allele are associated with severe intervillous and decidual pathologies in patients with pregnancy loss. Differences in pathologic grades of MTHFR C677T TT genotype could support the hypothesis that further periconceptional treatment for pregnancy loss could be customized depending on single nucleotide polymorphisms.
Introduction
Pregnancy loss is among the most common obstetric complications and affects up to 15% of pregnancies.
Recurrent pregnancy loss affects 4.2% of pregnancies and results in high medical, emotional, social and economic burdens. [1] [2] [3] [4] Despite its frequency and significant impact on individuals and society, reliable screening markers for risk of pregnancy loss remain insufficient. The trend of care for pregnant patients, 5, 6 as well as the shift in reproduction in modern society toward the late fourth or even early fifth decade of female life, along with the ever-increasing use of assisted reproductive technologies further emphasizes the need for such markers. Development of early pregnancy markers for risk of pregnancy loss could be based only on a deeper knowledge of the factors and mechanisms underlying pregnancy loss. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is common worldwide 7, 8 as well as in Japan, with at least 13% of the Japanese population carrying the TT genotype and 55% carrying the T allele. 9 Many studies identified an association between the MTHFR C677T polymorphism TT genotype and recurrent pregnancy loss or spontaneous abortion. [10] [11] [12] [13] [14] [15] [16] [17] Furthermore, the mechanism underlying these associations remains obscure. Although Gris et al. 18 reported an association between placental pathologic findings and the MTHFR C677T TT genotype in patients with another coexisting thrombophilia and late pregnancy loss, to our knowledge no studies have yet shown that the TT genotype alone could cause this effect.
To elucidate the mechanisms underlying the association between the MTHFR C677T TT genotype and pregnancy loss, we performed a cross-sectional study on patients presenting with the condition. We hypothesized that the TT genotype alone is associated with some pathology of the decidua or chorion.
Methods

Study design
We performed a cross-sectional observational multiinstitutional study of Japanese patients experiencing pregnancy loss between May 2010 and December 2013 at Osaka Women's and Children's Hospital (former name, Osaka Medical Center for Maternal and Child Health [MCH] ) and Fujita Clinic (Osaka, Japan). This study was approved by the MCH Ethics Committee. Staff interviewed patients about previous pregnancies and identified the number of experienced pregnancies, deliveries, miscarriages and stillbirths. All patients were of Japanese ethnicity, and their miscarriages had been treated by surgical evacuation. We defined pregnancy loss as a miscarriage or stillbirth when at least the gestational sac had been diagnosed in the uterus by medical personnel experienced with ultrasound. Exclusion criteria included anomalies in the female reproductive system, type 1 or 2 diabetes, antiphospholipid syndrome, 19 protein C or S deficiency, immunologic and thyroid disorders that could increase the risk of miscarriage, parental chromosomal abnormalities, fetal chromosomal anomalies in the product of conception or structural anomaly of the fetus. All patients signed informed consent forms, and 3-6 mL venous blood was collected from each patient.
MTHFR C677T polymorphism genotyping
Patient DNA was extracted and frozen at −80 C. Patient genotyping for the MTHFR C677T polymorphism was performed by a researcher blinded to patient history and pathologic results. We used a previously described protocol for MTHFR C677T genotyping 19 with some modifications. Patient genotypes were determined by polymerase chain reaction (PCR) followed by HinfI digestion of the PCR product. Primers used for PCR were forward primer, C for 5 min. The length of the amplification product was 198 base pairs (bp). The restriction reaction was performed overnight (at least 5 h) at 37 C in a mixture containing 36.0 μL PCR product, 6.0 μL 10× H buffer, 1.2 μL HinfI enzyme (10 U/μL; Toyobo Co.) and 16.8 μL doubledistilled water. The lengths of the restriction products were 175 and 23 bp. The PCR amplification product and fragments after restriction digestion were separated on a 4% NuSieve agarose gel (Lonza Rockland, Inc.), stained with ethidium bromide.
Pathologic examination
Miscarriages were examined pathologically at Osaka Women's and Children's Hospital (Osaka, Japan) by an experienced pathologist. The samples were stained with hematoxylin and eosin (Muto Pure Chemicals, Co., Ltd.) and investigated for decidual fibrin (DF), fibrin deposits into intervillous spaces (intervillous fibrin [IF]), presence or absence of decidual thrombosis (DT) and thrombosis in the intervillous spaces (intervillous thrombosis [IT] ). The fibrin deposits and thromboses in uterine decidua or intervillous spaces were classified into four categories based on their extent and severity. For DF and IF, grades 0 to 3 were ≤10%, 11-30%, 31-70% and >70% fibrin per field at lower magnification, respectively. For DT and IT, grades 0 to 3 were 0, 1-3, 4-10 and >10 thrombi per field at lower magnification, respectively. Each case was assigned the highest grade of the respective pathology found from at least 10 (average of approximately 20) fields under the light microscope. In some cases, evacuated samples for the pathology assay did not contain decidua or villi, rendering pathology assessment impossible for those cases.
Statistical analysis
The overall differences in age, body mass index (BMI), gravidity, parity, number of pregnancy losses and gestational period when the pathologic sample was obtained were determined by a nonparametric Kruskal-Wallis test after a Shapiro-Wilk normality test using JMP 10.0. Predictive value of the pathologic findings for MTHFR C677T was calculated 20 with SPSS version 14.0 (SPSS, Inc.) using chi-square tests. The Hardy-Weinberg equilibrium was calculated with a Hardy-Weinberg equilibrium calculator (http:// www.oege.org/software/hwe-mr-calc.shtml). Statistical significance was determined as P less than 0.05.
Results
Of 300 patients contacted for the study, 271 provided informed consent and 28 were excluded according to exclusion criteria, resulting in 243 (81%) enrolled in the study (Table S1 , Supporting Information). Parental chromosomal analysis was done in patients with more than three miscarriages. Variables were tested for distribution normality using the Shapiro-Wilk test, and a nonparametric Kruskal-Wallis test was used for patient age, BMI, gravidity, parity, number of pregnancy losses and gestational period when the pathologic sample was obtained. There was no significant genotype difference according to age (P = 0.0897), BMI (P = 0.9014), gravidity (P = 0.2567), parity (P = 0.3905), number of pregnancy losses (P = 0.4851) or gestational period when the pathologic sample was obtained (P = 0.6398; Table 1 ). Figure 1 shows one typical example of each of the four pathologic grades. The number of the pathologic findings, DF, IF, DT, and IT, is summarized in Table 2 . Grade 1 fibrin and thrombosis was observed predominantly in the intervillous space. An overview of the features of each pathologic finding is shown in Table S2 .
The incidence of each MTHFR C677T polymorphism genotype is described among the four pathologic grades. Figure S1 shows the gel image of each genotype. Grade 1 IF was observed predominantly in 48.2% of CC, 45.7% of CT, and 52.3% of TT genotypes, whereas grade 1 IT was observed predominantly in 50.6%, 50.0% and 47.7%, respectively ( Table 3) .
Findings of intervillous and decidual pathologies versus MTHFR C677T polymorphism are shown in Tables 4 and S3 . Genotype distribution of MTHFR C677T polymorphisms (C/C 83, C/T 116 and T/T 44) among study subjects did not deviate from HardyWeinberg equilibrium (χ 2 = 0.10; P = 0.75). We evaluated the probability of association among any particular type of intervillous or decidual pathology and their combinations with an MTHFR C677T. The results are shown as odds ratios (OR) with 95% confidence intervals (CI ; Tables 4 and S3 ). There were significantly more T allele carriers and TT genotype patients among patients with severe IT (pathologic grade IT 3) (OR 1.653, 95% CI 1.039-2.630, P = 0.0328 and OR 2.246, 95% CI 1.058-4.766, P = 0.0320, respectively) and patients with severe thrombosis (pathologic grade, IT 3 also DT 3: designated as pathologic score, IT + DT = 6) (OR 2.602, 95% CI 1.205-5.618, P = 0.0121 and OR 3.375, 95% CI 1.123-10.143, P = 0.0346, respectively). The CC genotype was protective against the four studied pathologic grades (Tables 4 and S3 ).
Discussion
Fibrin deposition is associated with recurrent pregnancy loss, preterm birth, intrauterine growth restriction or stillbirth and often is observed microscopically as encircling (perivillous) or connecting (intervillous) each villous. Rohr's fibrin is a massive IF, whereas Breus mole is a massive subchorionic hematoma. Breus mole is associated with preterm and intrauterine fetal death, which usually occurs after the second trimester. 21 However, the criteria of these pathologic features are unclear in some cases and are not yet organized. We classified fibrin deposition and thrombosis in the intervillous space or decidual membrane Figure 1 Four different grades of placental pathology. For decidual fibrin (a-d) and intervillous fibrin (e-h), grades 0-3 were <10%, 11-30%, 31-70% and >70% fibrin per field, respectively. Grades 0-3 for decidual thrombosis (i-l) and intervillous thrombosis (m-p) were 0, 1-3, 4-10 and >10 thrombi per field, respectively. Scale bar: 300 μm. by measuring the occupied area under the microscopic field.
Of particular interest is that patients with grade 3 DT and IT had a three-fold higher probability of carrying the MTHFR C677T in a recessive model (Table 4 and S3). Given the suggestion that all placentas from abnormal deliveries or miscarriages undergo pathology examination, 22 this finding provides clinical ground to the practice of checking the MTHFR C677T genotype in patients with severe DT and IT. Indeed, such patients could be treated with folic acid, thereby bypassing the MTHFR enzyme, instead of anticoagulants. Antepartum anticoagulation is not warranted among patients with less thrombogenic thrombophilia, as in those harboring the TT genotype of MTHFR C677T polymorphism, and who lack a history of venous thromboembolism. 23 The effect of higher doses of folic acid in the periconceptional period is well established to reduce the risk of neonatal neural tube defects. 24 As folate enrichment of cereals is not obligatory in Japan, it is highly possible that the cohort in this study included folate-depleted patients. On the other hand, there is no evidence to support use of 5 mg folic acid to reduce the risk of recurrent miscarriage. 25 Our data could benefit future pregnant women in that they could provide insight into potential intervention strategies according to the previous pathologic status of pregnancy loss placenta for periconceptional treatment with appropriate folic acid.
The significance of the association between the MTHFR C677T TT genotype and grade 3 DT and IT compared with grade 1 or 2 is also noteworthy (Table 4 ). Trophoblast and decidua are fast-growing tissues with high methionine requirements for DNA methylation and protein synthesis, and the link between the TT genotype or T allele and higher plasma homocysteine levels is well established.
26-29
Therefore, we speculated that grade 3 IT and DT in MTHFR C677T TT genotype patients occurs at points of higher local homocysteine concentrations. These might arise from insufficient homocysteine remethylation caused by diminished 5-methyltetrahydrofolate resynthesis as a result of decreased MTHFR activity in these patients. 30 As expected from the current trend in childbearing age in developed countries, the mean patient age in our study was in the middle thirties (Table 1) . Although in the past this might be considered a study limitation, with the ever-growing age of pregnant women, our study might be accepted to completely mirror contemporary everyday practice. However, a similar study among younger patients could be suggested. All fetal chromosomal abnormalities confirmed upon subsequent examination were excluded from the present study to simplify the condition. However, associations between the MTHFR C677T TT genotype and miscarriage with fetal chromosomal aberration could be studied in our future research.
Another field for future research is the association between decidual and intervillous pathologies and serum and red blood cell folate levels, as well as in situ homocysteine levels. When folate concentration is adequate, plasma homocysteine levels are normal and independent of genotype, whereas patients with the MTHFR C677T TT genotype might require higher folate intake to normalize homocysteine metabolism. 24 It is reasonable to hypothesize that lower folate intake results in situ in higher homocysteine concentrations, triggering coagulation and leading to severe IT and DT. In fact, lack of measurements of serum and red blood cell folate levels and of in situ homocysteine levels represents a limitation of our study.
Another potential limitation is that the study recruited patients from a core medical institution concentrating on high-risk patients with recurrent pregnancy loss. This possibly was the reason for the similar gravidity and parity among the three MTHFR C677T genotype groups, as patients with a 'favorable' MTHFR C677T genotype also could experience pregnancy loss. Although outside the aim of our study, a similar study recruiting patients from primary obstetrics practices not specialized in recurrent pregnancy loss could be suggested.
The significant association of grade 3 DT and IT with the MTHFR C677T TT genotype suggested the necessity for future studies of associations between this genotype and mild pre-eclampsia, 31 given that pre-eclampsia also has been associated with microthrombosis of small vessels. 32 This study also invites further investigation of the imminent risk of pregnancy loss in patients presenting with threatening miscarriage with or without severe IT or DT visualization by ultrasound or other imaging techniques, as well as the prospect of successfully treating these patients with folic acid to reduce high homocysteine levels in the fetal chorion or maternal decidua. The most appropriate dose of folic acid for prevention of pregnancy loss remains to be investigated in the future.
In brief, this is the first study reporting the histological grading of placental features of IF, IT, DF and DT among patients with pregnancy loss. A cross-sectional study was also performed to investigate the relationship between the four pathologic statuses and maternal MTHFR C677T genotypes. There were significantly more T allele carriers and TT genotype patients among those with severe IT and with severe IT and DT.
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